📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Alps Industries Sets Dec 19 Record Date for 99% Capital Reduction and Consolidation
Alps Industries has announced December 19, 2025, as the record date for a major capital restructuring mandated by an NCLT-approved resolution plan. The company's equity share capital will undergo a 99% reduction, decreasing from Rs. 39.11 crore to just Rs. 39.11 lakh. Following this reduction, the face value will drop to Rs. 0.10, and every 10 such shares will be consolidated into one share with a face value of Rs. 1.00. This process significantly diminishes the value and quantity of shares held by existing retail investors.
Key Highlights
Record date for capital reduction and consolidation fixed for December 19, 2025
Equity share capital to be reduced by 99%, from Rs. 39.11 crore to Rs. 39.11 lakh
Face value of shares reduced from Rs. 10 to Rs. 0.10 per share initially
Consolidation of 10 shares of Rs. 0.10 each into 1 share of Rs. 1.00 face value
Restructuring is part of the Resolution Plan approved by the Hon'ble NCLT Prayagraj
💼 Action for Investors
Investors should exercise extreme caution as the 99% capital reduction effectively wipes out the majority of existing equity value. Current shareholders will see a drastic decrease in the number of shares held and the total value of their investment.
Ind-Swift Labs Receives GMP Certificate from NNGYK-Hungary
Ind-Swift Laboratories Limited has received a Good Manufacturing Practice (GMP) certificate from the National Center for Public Health and Pharmacy (NNGYK-Hungary) following an EUDRA GMP inspection in November 2025. This certification, valid for 3 years, allows the company to access European and other markets. The company's Global Business Unit already holds certifications from WHO-GMP, TGA (Australia), MHRA (UK), SAPRA (South Africa) and EU-GMP. This GMP certification reinforces the company's commitment to quality and regulatory compliance.
Key Highlights
Received GMP certificate from National Center for Public Health and Pharmacy (NNGYK-Hungary)
Certificate is valid for a period of 3 years
EUDRA GMP inspection conducted in November, 2025
Global Business Unit holds certifications from WHO-GMP, TGA (Australia), MHRA (UK), SAPRA (South Africa) and EU-GMP
💼 Action for Investors
Investors should view this positively as it expands the company's market access and reinforces its commitment to quality. Monitor the company's performance in the European market over the next few years.
Zydus Lifesciences: FDA Accepts CUTX-101 NDA Resubmission for Menkes Disease
Zydus Lifesciences' wholly-owned subsidiary, Sentynl Therapeutics, announced that the FDA has accepted the resubmission of its New Drug Application (NDA) for copper histidinate (CUTX-101) to treat Menkes disease in pediatric patients. The FDA has set a new PDUFA target action date of January 14, 2026. The original CRL cited cGMP compliance observations at the manufacturing site but did not raise concerns about CUTX-101's efficacy or safety data, which previously demonstrated an almost 80% reduction in the risk of death compared to an untreated control group. If approved, CUTX-101 will be the first FDA-approved treatment for Menkes disease.
Key Highlights
FDA accepted NDA resubmission for CUTX-101 on December 15, 2025
New PDUFA target action date is January 14, 2026
CUTX-101 demonstrated nearly 80% reduction in risk of death in clinical trials
Menkes disease impacts an estimated 1 in 34,810 to 1 in 8,664 live male births
Median overall survival was 177.1 months for CUTX-101 ET cohort compared to 16.1 months for the untreated historical control cohort
💼 Action for Investors
Investors should monitor the FDA's decision on CUTX-101 by January 14, 2026, as approval would be a significant positive catalyst for Zydus Lifesciences, given the unmet need for Menkes disease treatment.
KEI Industries gets CareEdge-ESG1 rating with score of 72.8
KEI Industries has been assigned an ESG score of 72.8 by CARE ESG Ratings Limited, earning a 'CareEdge-ESG1' rating. This rating signifies KEI Industries' leadership in managing Environmental, Social, and Governance (ESG) risks. The rating was communicated via email and letter, both dated 15.12.2025. This disclosure is in compliance with SEBI regulations.
Key Highlights
CARE ESG Ratings Limited assigned an ESG Score of 72.8 to KEI Industries.
KEI Industries received 'CareEdge-ESG1' rating.
Rating received via email on 15.12.2025 at 03.36 PM.
Rating letter received on 15.12.2025 at 05.52 PM.
💼 Action for Investors
The positive ESG rating suggests improved sustainability practices, which can be a factor for long-term investors. Monitor KEI Industries' future ESG performance and disclosures for continued improvement.
Standard Glass Lining Tech Shareholders Approve ESOP 2024 and Company Name Change
Shareholders of Standard Glass Lining Technology Limited have approved six special resolutions via postal ballot, including the ratification and amendment of the 'Employee Stock Option Plan 2024'. The resolutions also extend ESOP benefits to employees of subsidiary and associate companies to align interests across the group. Additionally, the company received overwhelming support for a name change and an amendment to its objects clause in the Memorandum of Association. All resolutions passed with over 99% of votes in favor, reflecting strong shareholder confidence in management's strategic initiatives.
Key Highlights
Ratification and amendment of 'Employee Stock Option Plan 2024' passed with 100% and 99.99% favor respectively.
Extension of ESOPs to employees of subsidiary and associate companies approved with 100% and 99.45% support.
Resolution for changing the company name and amending the Memorandum of Association passed with nearly 100% support.
A total of 155,883,808 votes were polled, representing 78.14% of the total outstanding shares of the company.
The voting process involved 258 members exercising their votes through remote e-voting between Nov 15 and Dec 14, 2025.
💼 Action for Investors
Investors should monitor the official announcement of the new company name and any subsequent shifts in business focus following the amendment of the objects clause. The broad approval for ESOPs indicates a management focus on long-term talent retention and alignment.
Canara Bank Issues E-Auction Notice for Assets of Astron Paper's Subsidiary Balaram Papers
Canara Bank has issued an e-auction sale notice for the assets of Balaram Papers Private Limited, a wholly-owned subsidiary of Astron Paper & Board Mill Limited. The auction involves the sale of plant, machinery, and approximately 10,217 sq. mtrs of industrial land located in Mehsana, Gujarat. This action is being taken under the SARFAESI Act, 2002, which typically follows a default in loan repayments. The parent company is currently evaluating legal implications and potential next steps to address the recovery action.
Key Highlights
Canara Bank issued an E-auction sale notice dated November 21, 2025, for subsidiary Balaram Papers.
Assets include plant, machinery, and 10,217 sq. mtrs of NA industrial land in Ganeshpura, Mehsana.
Action initiated under the SARFAESI Act, 2002, and Security Interest (Enforcement) Rules, 2002.
Balaram Papers Private Limited is a 100% wholly-owned subsidiary of Astron Paper & Board Mill Limited.
The company is seeking legal advice to evaluate the implications of this asset recovery action.
💼 Action for Investors
Investors should exercise extreme caution as the auction of core assets indicates severe financial distress or debt default at the subsidiary level. Monitor the company's ability to settle dues or obtain a stay order to prevent the loss of these manufacturing assets.
S&P Global Revises IIFL Finance Outlook to Positive; Affirms 'B+' Rating
S&P Global Ratings has revised the credit outlook for IIFL Finance Limited from 'Stable' to 'Positive', signaling a potential upgrade in the future. The agency affirmed the company's long-term issuer credit rating at 'B+' and short-term rating at 'B'. Additionally, the 'B+' long-term foreign currency rating on the company's outstanding U.S. dollar denominated senior secured notes was also affirmed. This revision reflects improving confidence in the company's credit profile and financial stability.
Key Highlights
S&P Global Ratings revised the credit outlook from Stable to Positive on December 15, 2025
Affirmed 'B+' long-term and 'B' short-term issuer credit ratings for IIFL Finance
Affirmed 'B+' long-term foreign currency issue rating on USD denominated senior secured notes
Positive outlook indicates the possibility of a rating upgrade if current financial trends continue
💼 Action for Investors
The outlook revision is a positive indicator for the company's future borrowing costs and market reputation. Investors should monitor if this leads to a formal rating upgrade, which could further boost the stock's valuation.
INDOWIND: NSE & BSE approve listing of Rights Issue shares
Indowind Energy Limited received in-principle approval from NSE and BSE for listing of equity shares issued under Rights Issue. The approval is for listing 3,22,00,434 Equity Shares. The shares are priced at ₹15.35 per Equity Share, which includes a premium of Rs.5.35 per share. The listing will occur after confirmation from NSDL/CDSL regarding credit to beneficiaries' accounts.
Key Highlights
Received in-principle approval from NSE and BSE for Rights Issue listing
Listing of 3,22,00,434 Equity Shares approved
Issue price is ₹15.35 per Equity Share
Includes a premium of Rs.5.35 per Equity Share
💼 Action for Investors
Shareholders can anticipate the listing of the rights issue shares. Monitor your demat account for credit of shares post confirmation from NSDL/CDSL.
Astron Paper: Canara Bank E-auction Notice for Subsidiary Balaram Papers
Canara Bank has issued an E-auction sale notice dated 21.11.2025 regarding assets of Balaram Papers Private Limited, a wholly-owned subsidiary of Astron Paper & Board Mill Limited. The auction is under the Securitisation and Reconstruction of Financial Assets and Enforcement of Security Interest Act, 2002. The properties include plant and machinery and NA Land located at Revenue Survey No. 258 in Mehsana. Astron Paper is evaluating the implications and will take legal steps.
Key Highlights
E-auction sale notice issued by Canara Bank on 21.11.2025
Assets of Balaram Papers Private Limited to be auctioned
Property located at Revenue Survey No. 258 in Mehsana
Land area is about -10217 sq. mtrs
💼 Action for Investors
Investors should closely monitor Astron Paper's response to the auction notice and assess the potential financial impact on the company. Review company updates for further information.
Ansal Properties Reports Q1 FY26 Standalone Results Amid Ongoing Insolvency Process
Ansal Properties & Infrastructure Limited (APIL) has submitted its standalone financial results for the quarter ended June 30, 2025, while currently undergoing the Corporate Insolvency Resolution Process (CIRP). The company was unable to provide consolidated financial results, citing significant difficulties in obtaining data from its subsidiaries. The Resolution Professional (RP) has cautioned that these results are subject to valuations and transaction audits, which may lead to significant changes in the reported numbers. The powers of the company's board remain suspended, and affairs are managed by the RP.
Key Highlights
Company has been under Corporate Insolvency Resolution Process (CIRP) since February 25, 2025.
Only standalone results for Q1 FY26 were submitted; consolidated results were omitted due to lack of data from subsidiaries.
Resolution Professional Navneet Kumar Gupta signed the results for compliance but does not vouch for the financial position or performance.
Financial statements are subject to pending valuations and transaction audits which may result in significant future revisions.
Specific projects like Serene Residency and Fernhill are being managed by separate Resolution Professionals or under specific resolution plans.
💼 Action for Investors
Investors should exercise extreme caution as the company is in insolvency and the RP has explicitly warned against relying on these results for investment decisions. The lack of consolidated data and potential for significant financial revisions make the stock highly speculative and risky.
SBI to sign EURO 150 million Line of Credit with KfW
State Bank of India (SBI) will be signing a EURO 150 million Line of Credit with KfW (German Development bank). This credit line is dedicated to financing Climate Friendly Energy Generation projects. The signing is scheduled for December 16, 2025, at KfW Headquarters Frankfurt. This initiative indicates SBI's commitment to sustainable financing and could enhance its reputation among environmentally conscious investors.
Key Highlights
SBI to sign EURO 150 million Line of Credit with KfW
Line of Credit is for financing Climate Friendly Energy Generation projects
Signing scheduled on 16.12.2025 at KfW Headquarters Frankfurt
💼 Action for Investors
Investors should note SBI's increasing focus on green financing, which could positively impact its long-term sustainability and attract ESG-focused investments. Monitor the deployment and impact of this EURO 150 million credit line on SBI's financials and environmental footprint.
Krishival Foods Approves Letter of Offer for Rights Issue
Krishival Foods Limited's Rights Issue Committee approved the Letter of Offer for its proposed Rights Issue. The committee also approved filing the Letter of Offer with SEBI and stock exchanges, including BSE Limited and National Stock Exchange of India Limited. The meeting commenced at 4:00 p.m. (IST) and concluded at 06:00 p.m. (IST). This decision signals the company's intent to raise capital through the issuance of rights to existing shareholders.
Key Highlights
Approved Letter of Offer for proposed Rights Issue
Approved filing with SEBI and Stock Exchanges
Meeting commenced at 4.00 p.m. (IST) and concluded at 06.00 p.m. (IST)
💼 Action for Investors
Shareholders should review the Letter of Offer once available to understand the terms of the Rights Issue and assess whether to participate. Monitor company announcements for further details on the issue price and ratio.
GOCL Corp to Merge with Hinduja National Power; Share Swap Ratio Set at 206:10,000
GOCL Corporation has approved a scheme of merger to absorb Hinduja National Power Corporation Limited (HNPCL), a move that will significantly scale its operations. HNPCL reported a substantial turnover of ₹2,436.94 crores in FY25, compared to GOCL's consolidated turnover of just ₹18.19 crores. The merger involves a share swap ratio of 206 GOCL shares for every 10,000 HNPCL shares, resulting in the promoter stake increasing from 67.82% to 74.87%. This strategic consolidation aims to integrate HNPCL's thermal power business and surplus cash flows into GOCL's listed entity.
Key Highlights
HNPCL's FY25 turnover of ₹2,436.94 Cr to be integrated with GOCL's ₹18.19 Cr base
Share swap ratio fixed at 206 GOCL shares (FV ₹2) for every 10,000 HNPCL shares (FV ₹10)
Promoter shareholding in GOCL to increase from 67.82% to 74.87% post-merger
Total equity shares of GOCL will expand from 4.95 crore to 7.45 crore shares
HNPCL recorded a strong half-year turnover of ₹1,398.27 Crores ending September 2025
💼 Action for Investors
This is a transformative merger that pivots GOCL into a major power generation player; investors should monitor the regulatory approval timeline. While the equity base expands, the massive revenue addition from HNPCL is likely to be value-accretive in the long term.
Indo Borax Promoters to Sell 50.80% Stake to Zenrock Chemicals at INR 256.30/Share
The promoter group of Indo Borax & Chemicals has signed a Share Purchase Agreement to sell their entire 50.80% stake (1,63,00,230 shares) to Zenrock Chemicals and associated funds. The transaction is priced at INR 256.30 per share, which triggers a mandatory open offer for an additional 26% stake from public shareholders. Following the completion of this deal, the current promoters will exit the company entirely, leading to a complete change in management and control. Zenrock Chemicals will appoint three nominee directors to the board, while existing promoter-directors will resign.
Key Highlights
Promoters to divest 1,63,00,230 shares, representing 50.80% of the total paid-up equity capital.
The transaction price is set at INR 256.30 per share under the Share Purchase Agreement (SPA).
Acquirers will launch a mandatory Open Offer for an additional 26% of the expanded voting share capital.
Complete management transition planned with the resignation of Mr. Sajal Jain and Mr. Govind Ramlal Parmar.
New acquirers (Zenrock Chemicals and ISAF III) will appoint 3 nominee directors to the Board.
💼 Action for Investors
Investors should evaluate the open offer price of INR 256.30 against the current market price to decide on participating in the exit opportunity. The entry of new institutional-backed management could potentially re-rate the stock, but investors should watch for the new leadership's strategic roadmap.
INDOBORAX: Promoter Group to Sell 50.80% Stake, Open Offer Triggered
Indo Borax & Chemicals Limited announced that its promoter group will sell an aggregate of 1,63,00,230 equity shares, constituting approximately 50.80% of the total paid-up equity share capital, to Zenrock Chemicals Private Limited, India Special Assets Fund III, ISAF III Onshore Fund, and Special Situation India Fund. This transaction triggers an open offer for acquisition of an additional 26% of the expanded voting share capital, in accordance with SEBI regulations. The per share price for the sale is INR 256.30. Upon completion, the sellers will be de-classified from being promoters.
Key Highlights
Promoter group to sell 50.80% stake in INDOBORAX.
Open offer triggered for an additional 26% of the expanded voting share capital.
Sale involves 1,63,00,230 equity shares.
Per share price for the sale is INR 256.30.
Sellers will be de-classified from promoter group after the transaction.
💼 Action for Investors
Investors should closely monitor the open offer details and evaluate whether to participate, considering the offer price and their investment strategy. Keep an eye on the new management's strategy post-acquisition.
Cohance Lifesciences Resubmits Financial Results for Q2 2026
Cohance Lifesciences Limited has resubmitted its Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2025, in machine-readable form, as per NSE requirements. The original results were submitted on November 12, 2025, and there are no changes in the financials. Standalone revenue from operations for the quarter ended September 30, 2025, was ₹497.79 crore, and net profit for the period was ₹94.19 crore. Consolidated revenue from operations for the quarter ended September 30, 2025, was ₹555.57 crore, with a net profit of ₹66.39 crore.
Key Highlights
Standalone revenue from operations for Q2 2026: ₹497.79 crore
Standalone net profit for Q2 2026: ₹94.19 crore
Consolidated revenue from operations for Q2 2026: ₹555.57 crore
Consolidated net profit for Q2 2026: ₹66.39 crore
Total standalone income for half year ended September 30, 2025: ₹1020.77 crore
💼 Action for Investors
Review the detailed financial results for Cohance Lifesciences to assess the company's performance and consider how it aligns with your investment strategy. Monitor future announcements for any significant changes in financial performance.
GOCLCORP approves merger of Hinduja National Power Corporation Limited
GOCL Corporation Limited's board approved a scheme of merger by absorption of Hinduja National Power Corporation Limited (HNPCL). The share exchange ratio is set at 206 shares of GOCL for every 10,000 shares of HNPCL. HNPCL's turnover for FY ended March 31, 2025, was ₹2436.94 Crores, while GOCL's consolidated turnover (excluding discontinued operations) was ₹18.19 crores. Post-merger, promoter shareholding in GOCL will increase from 67.82% to 74.87%.
Key Highlights
Share exchange ratio: 206 GOCL shares for every 10,000 HNPCL shares
HNPCL turnover FY25: ₹2436.94 Crores
GOCL turnover FY25 (excluding discontinued operations): ₹18.19 crores
Promoter shareholding in GOCL post-merger: 74.87%
Public shareholding in GOCL post-merger: 25.13%
💼 Action for Investors
Investors should closely monitor the progress of the merger and its impact on GOCL's future earnings and growth prospects. Consider the potential benefits of the merger, including consolidation of operations and enhanced shareholder value.
Solex Energy Partners with TT Vision to Advance Solar Automation
Solex Energy Limited has partnered with Malaysia's TT Vision to enhance solar manufacturing automation and talent development in India. The non-binding MoU aims to strengthen India's renewable energy manufacturing ecosystem. TT Vision will provide specialized technical training to Solex engineers, focusing on automation and inspection systems. Solex will gain preferential access to TT Vision’s automation technologies to support R&D and process optimization. The MoU is valid for an initial 36-month term.
Key Highlights
Solex Energy has a 4 GW production capacity for PV modules.
The MoU is valid for an initial 36-month term.
TT Vision will provide specialized technical training to Solex engineers in Penang, Malaysia.
Solex will assist TT Vision’s India entry by providing guidance on manufacturing setup.
💼 Action for Investors
Investors should monitor the progress of this partnership and its impact on Solex Energy's manufacturing capabilities and market position. Keep an eye on future definitive agreements related to jointly developed technologies.
TRANSWORLD Receives GST Order for ₹10,25,84,579
Transworld Shipping Lines Limited has received an order under Section 73(9) of the CGST/MGST Act, 2017, related to GST audit proceedings for FY 2021-22. The aggregate demand, including tax, interest, and penalty, amounts to ₹10,25,84,579. The company believes it has strong grounds to contest the order and intends to file an appeal. Transworld does not expect any material financial impact from this order.
Key Highlights
GST order received under Section 73(9) of the CGST/MGST Act, 2017
Aggregate demand of ₹10,25,84,579 including tax, interest and penalty
Order relates to GST audit proceedings for FY 2021-22
Order received on December 15, 2025
💼 Action for Investors
Investors should monitor the progress of the appeal filed by the company. While the company anticipates no material financial impact, any adverse outcome could potentially affect future earnings.
ATLANTAA Registers Redevelopment Agreement in Borivali East, Mumbai
Atlantaa Limited has registered a Development Agreement for the redevelopment of a plot admeasuring approximately 4,496 square meters in Borivali (East), Mumbai. The project, located at Highway Milton Co-operative Housing Society, is expected to deliver 1.75 lakh sq. ft. of saleable carpet area. The projected Gross Development Value (GDV) is ₹500 crores. This redevelopment project expands Atlantaa Limited's real estate footprint in the western suburbs of Mumbai.
Key Highlights
Development agreement for 4,496 square meters plot
Projected Gross Development Value (GDV) of ₹500 crores
Estimated 1.75 lakh sq. ft. of saleable carpet area
Located in Borivali (East), Mumbai
💼 Action for Investors
Investors should monitor the progress of this redevelopment project and its impact on Atlantaa Limited's revenue and profitability. This project could positively influence the company's future earnings.